FDA-approved botulinum toxin type A formulation containing 50 units per vial. Clinically proven to temporarily improve moderate to severe glabellar lines (89% improvement rate in clinical trials) and treat neuromuscular disorders. Requires reconstitution with 0.9% sodium chloride before administration.

Formulation Details:
• Potency: 50 units/vial (U-100)
• pH: 6.8-7.2 post-reconstitution
• Storage: 2-8°C (lyophilized form)
• FDA-approved manufacturing

Administration Protocol:
1. Reconstitute with preservative-free 0.9% NaCl
2. Use within 24 hours (refrigerated)
3. 30-gauge needle recommended
4. Multiple injection technique required
5. Post-treatment upright positioning (4h)

Medical Notice: Prescription-only neurotoxin. Contraindicated in neuromuscular disorders (myasthenia gravis, ALS). Potential side effects include ptosis (3.2% cases) and headache (9% cases). Clinical outcomes may vary ±15% based on injection technique and patient physiology.